argon has been researched along with Diabetes Mellitus, Type 2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ishijima, T; Iswara, A; Mukai, K; Nakajima, Y; Nakano, Y; Nakatani, T; Oe, M; Okuwa, M; Sugama, J; Tanaka, K; Tanaka, Y | 1 |
| Buyukbese, MA; Cetinkaya, A; Ozdemir, G; Ozdemir, M | 1 |
| Olk, RJ | 1 |
1 trial(s) available for argon and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Argon green (514 nm) versus krypton red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular edema.
Topics: Adult; Aged; Aged, 80 and over; Argon; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Fundus Oculi; Humans; Krypton; Lasers; Light Coagulation; Macular Edema; Male; Middle Aged; Prognosis; Prospective Studies; Visual Acuity | 1990 |
2 other study(ies) available for argon and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Wound healing in db/db mice with type 2 diabetes using non-contact exposure with an argon non-thermal atmospheric pressure plasma jet device.
Topics: Animals; Argon; Blood Glucose; Colloids; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Eosine Yellowish-(YS); Hematoxylin; Hydrogen Peroxide; Male; Mice; Mice, Inbred C57BL; Nitrogen; Oxygen; Plasma Gases; Wound Healing | 2022 |
Risk factors for ocular surface disorders in patients with diabetes mellitus.
Topics: Adult; Aged; Argon; Case-Control Studies; Corneal Diseases; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Humans; Lasers; Light Coagulation; Male; Middle Aged; Prospective Studies; Risk Factors; Tears | 2003 |